<p>Erythropoietin alfa is an erythropoiesis-stimulating agent (ESA) indicated for:<br />
<br />
Treatment of anemia due to:</p>

<ul>
	<li>Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis.</li>
	<li>Zidovudine in HIV-infected patients.</li>
	<li>The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.</li>
</ul>

<p>Reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery.<br />
<br />
Prevention of anemia of prematurity in infants with a birth weight of 750 to 1500 gm and gestational age of less than 34 weeks.</p>